PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, 500 5th Ave N, Seattle, WA 98109, USA.\', \'Independent Advisor, Stuart, FL, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.\', \'Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK.\', \'Independent Advisor, New York, NY, USA.\', \'Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, 500 5th Ave N, Seattle, WA 98109, USA. Electronic address: Peter.Dull@gatesfoundation.org.\', \'Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, 3401 Civic Center Blvd., Philadelphia, PA 19104, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(21)00658-710.1016/j.vaccine.2021.05.063
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34210573
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • Evidence for antibody as a protective correlate for COVID-19 vaccines.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34210573>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34210573>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all